Clario's Chief Information, Technology and Product Officer, Jay Ferro, recently joined Efficio’s Simon Lipscomb and Mert Erkan as a special guest on their podcast, “Spotlight on Procurement.” This episode covers a variety of topics that Jay weaves together to create a roadmap for leveraging the intersection of procurement and information technology to achieve optimal organizational transformation. ▶ Learn more about the episode and check it out here: https://lnkd.in/d-2B6BBJ Don’t miss it! #procurement #informationtechnology #innovation #clinicaltrials
Clario
Biotechnology Research
Philadelphia, Pennsylvania 100,152 followers
Transforming Lives by Unlocking Better Evidence | Decentralized clinical trials | Broadest endpoint technology
About us
Clario is a leading healthcare research and technology company that generates high quality clinical evidence for our pharmaceutical, biotech, and medical device partners. We offer comprehensive evidence generation solutions that combine eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Since our founding more than 50 years ago, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported clinical trials over 26,000 times in more than 100 countries. Our global team of science, technology, and operational experts have supported over 60% of all FDA drug approvals since 2019. For more information, visit Clario.com
- Website
-
https://clario.com/
External link for Clario
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Philadelphia, Pennsylvania
- Type
- Privately Held
- Founded
- 1972
- Specialties
- Cardiac Solutions, Medical Imaging, eCOA, Respiratory Solutions, Precision Motion, Specialty Solutions, Clinical Adjudication, and Artificial Intelligence
Locations
Employees at Clario
Updates
-
The Clario team is excited to meet you in Barcelona at #ESMO2024! Visit us at booth #442 to discover how our cutting-edge oncology trial solutions can transform your clinical trials. ⬇
📢 Attending next month's ESMO Congress? Stop by Clario booth #442! The Clario team is excited to share how our cutting-edge oncology trial solutions are helping to transform the clinical trials landscape. Don’t miss your chance to: ▫️Learn about our groundbreaking technologies to enhance data quality and accuracy ▫️Discover how Clario can streamline your oncology trials ▫️Engage in discussions and network with industry key opinion leaders Join us to discuss how our team of experts could help you better measure efficacy, ensure safety, and assess patient quality of life in your oncology trials. See you in Barcelona! ➡️ https://hubs.li/Q02LgrLY0 #oncology #clinicaltrials #ESMO2024
-
Did you know it takes an average of 13 years for an Alzheimer's disease (AD) drug to progress from preclinical studies to regulatory review? AD trials are challenging. The slowly progressive disease results in longer timelines, lengthy recruitment periods, high drop-out rates, and greater expenses. Clario can help mitigate those challenges. ➡️ Check out this case study to learn how the Clario team helped a large pharma company gain accelerated FDA approval for a ground-breaking AD treatment. https://hubs.li/Q02MJDgQ0 #Alzheimers #AlzResearch #ClinicalTrials #CRO #Biotech #ClarioNeuroscience
-
Save the date for our upcoming webinar! "Advancing Multiple Sclerosis Clinical Trials: Integrating Medical Imaging, Precision Motion Analysis, and eCOA Data for Enhanced Outcomes" 🗓️ September 17 ⏰ 11:00 - 12:00 ET This session will take a deep dive into how cutting-edge technologies are revolutionizing Multiple Sclerosis (MS) clinical trials. Discover how advanced imaging modalities that leverage AI, instrumented digital gait analysis, and eCOA enhancements such as dedicated rater training can support the generation of more accurate and reliable study results. Clario's presenters will be: Laura Khurana, MPH, Principal Scientific Advisor, eCOA Madhura Ingalhalikar, Ph.D., MRI Scientist, Neuroscience Medical Affairs Adam Jagodinsky, Ph.D., Principal Scientific Advisor, Precision Motion ➡️ Secure your spot for this insightful session about advancements in MS research! https://hubs.li/Q02Mbmgv0 #clinicaltrials #multiplesclerosis #ecoa #precisionmotion #medicalimaging
-
✨ The Clario office and our team in Bangalore, India keep reaching new heights! We recently refreshed our workspace there, giving it a sleek new design to inspire and foster collaboration. Earlier this week, the team in India celebrated their revitalized space. Special guests on hand included our EVP and GM of Digital Physiology, Ellen Street (Conway); SVP of Client Success and Customer Experience, Kristina Lowe; VP of Global Project Management, Shadi B. Zoghi; VP of Clinical Study and Data Operations, Kamlesh Naidu; and VP of Global Customer Care, Anthony Levite. Congratulations to everyone involved in the successful office renovation — your hard work has truly transformed the office into a beautiful space! 🙌
"We're excited to unveil Clario newly renovated Bangalore, India office and refreshed outlook, celebrating a major milestone in our journey." 🎉
-
+1
-
📣 Don't miss Clario's respiratory team in Vienna at the #ERSCongress2024! They'll share seven poster presentations highlighting the latest advancements in respiratory testing. Stop by booth B6.01 to chat with our experts and for a demo of our respiratory solutions. We’re excited to connect with you to explore what’s new for your clinical trials! ➡️ Learn more about our activities at next month's ERS Congress: https://hubs.li/Q02M278V0 European Respiratory Society #respiratory #clinicaltrials #clinicalresearch #ERS2024
-
We are excited to share our most recent ESG report for the calendar year 2023! 🌿 We've continued to make great progress since the release of our inaugural report in 2022. Among other achievements, this year's report highlights the advancements we've made in responsible artificial intelligence (#AI), employee program investments, and ambitious science-based sustainability targets. ➡️ Check out the full report to learn more about our efforts to drive positive change in the clinical trials' community and beyond. https://hubs.li/Q02LVhNY0 #ESG #ESGreport #Sustainability
-
Why is an enhanced suicide risk detection strategy so important to protect patient safety in clinical trials? Discover the impact of eC-SSRS and C-SSRS in our free, on-demand webinar, "Accurate Suicide Risk Detection With eC-SSRS: Ensuring the Safety of Trial Participants and Treatments in Oncology and Beyond." Join esteemed experts Dr. Kelly Posner, Dr. John Greist, and Clario eCOA scientific advisor Olivia Thomas-Barrineau as they delve into how the Columbia-Suicide Severity Rating Scale (C-SSRS) and eC-SSRS play a crucial role in protecting clinical trial participants, safeguarding drug compounds, and demonstrating the benefits of treatments. Don't miss out on this valuable resource! https://hubs.li/Q02LJbxM0
-
If you'll be in Boston next week to attend the 8th Annual IPF Summit, be sure to sit in on a special poster presentation from Clario's Senior Director of Respiratory Solutions, Philip Lake, Ph.D.! Session title: "The Potential for Baseline Spirometry Variability to Generate Increased Treatment Response in IPF." 📅 August 21 🕒 3:15 PM EST Don’t miss this insightful session! https://hubs.li/Q02LqtRf0
-
📢 Attending next month's ESMO Congress? Stop by Clario booth #442! The Clario team is excited to share how our cutting-edge oncology trial solutions are helping to transform the clinical trials landscape. Don’t miss your chance to: ▫️Learn about our groundbreaking technologies to enhance data quality and accuracy ▫️Discover how Clario can streamline your oncology trials ▫️Engage in discussions and network with industry key opinion leaders Join us to discuss how our team of experts could help you better measure efficacy, ensure safety, and assess patient quality of life in your oncology trials. See you in Barcelona! ➡️ https://hubs.li/Q02LgrLY0 #oncology #clinicaltrials #ESMO2024